Work

The FDA Approves Aducanumab for Alzheimer’s Disease, Raising Important Scientific Questions1

Year: 2021

Type: editorial

Source: Journal of Alzheimer s Disease

DOI: 10.3233/jad-210736

Authors: Jack C. de la Torre, Francisco Gonzalez-Lima

Institutions: Universitat de València, The University of Texas at Austin

Language: English

Topic: Alzheimer's disease research and treatments

Subfield: Physiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W3181899489

Cites: 3

Cited by: 24

Related to: 10